Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death
worldwide. In the past decade, there have been improvements in non-drug therapies and …

The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice
are becoming increasingly related to sustained virological response after hepatitis C …

Advances in the surgical and systemic therapeutic landscape of hepatocellular carcinoma
have increased the complexity of patient management. A dynamic adaptation of the …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Objective: We sought to develop a “Model Of Recurrence After Liver transplant”(MORAL) for
hepatocellular carcinoma (HCC). Background: The Milan criteria are used to allocate livers …

Background & Aims United Network of Organ Sharing (UNOS) has adopted uniform criteria
for downstaging (UNOS-DS) of hepatocellular carcinoma (HCC) before liver transplantation …

It would be impossible to summarise all of the significant developments in the surgical
management of hepatocellular carcinoma (HCC), even just over the past year, in a …

Expansion of the liver transplantation indication criteria for patients with hepatocellular
carcinoma (HCC) has long been debated. Here we propose new, expanded living‐donor …